Clinical Trial Update: An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study [Phase 2]

View source ↗

Summary

An extension study for participants who completed the treatment period of a qualifying Phase 2 parent study in dermatomyositis has completed. Results from the e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Drugs mentioned

• Pfizer investigational product

Snippet

Sponsor: Pfizer | Conditions: Dermatomyositis | Phase 2 | Status: COMPLETED | Results posted: 2025-02-06